Gynecomastia: A Rare Adverse Effect of Methylphenidate in an Adolescent Boy.

Clin Psychopharmacol Neurosci

Department of Child and Adolescent Psychiatry, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

Published: May 2020

Gynecomastia is a benign condition developing in association with localized fat deposition and glandular tissue proliferation in the breast in males, and characterized by breast growth. Drug is one of the most important factors in the etiology of gynecomastia. Methylphenidate is a commonly preferred and well-tolerated drug in the treatment of attention deficit hyperactivity disorder in children and adolescents. Gynecomastia is an uncommon side-effect of methylphenidate use. We report a case of bilateral gynecomastia developing in a dose-dependent manner during methylphenidate monotherapy and resolving with discontinuation of medication in a 15-year-old patient with a history of a similar side-effect during previous use of the drug. To the best of our knowledge this is one of the few case reports of gynecomastia developing in association with methylphenidate.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242103PMC
http://dx.doi.org/10.9758/cpn.2020.18.2.337DOI Listing

Publication Analysis

Top Keywords

developing association
8
gynecomastia developing
8
gynecomastia
6
methylphenidate
5
gynecomastia rare
4
rare adverse
4
adverse methylphenidate
4
methylphenidate adolescent
4
adolescent boy
4
boy gynecomastia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!